250 related articles for article (PubMed ID: 32632179)
21. ILF2 enhances the DNA cytosine deaminase activity of tumor mutator APOBEC3B in multiple myeloma cells.
Kazuma Y; Shirakawa K; Tashiro Y; Yamazaki H; Nomura R; Horisawa Y; Takeuchi S; Stanford E; Konishi Y; Matsui H; Matsumoto T; Tanabe F; Morishita R; Ito S; Takaori-Kondo A
Sci Rep; 2022 Feb; 12(1):2278. PubMed ID: 35145187
[TBL] [Abstract][Full Text] [Related]
22. p53 controls expression of the DNA deaminase APOBEC3B to limit its potential mutagenic activity in cancer cells.
Periyasamy M; Singh AK; Gemma C; Kranjec C; Farzan R; Leach DA; Navaratnam N; Pálinkás HL; Vértessy BG; Fenton TR; Doorbar J; Fuller-Pace F; Meek DW; Coombes RC; Buluwela L; Ali S
Nucleic Acids Res; 2017 Nov; 45(19):11056-11069. PubMed ID: 28977491
[TBL] [Abstract][Full Text] [Related]
23. Aberrant APOBEC3B Expression in Breast Cancer Is Linked to Proliferation and Cell Cycle Phase.
Roelofs PA; Timmermans MAM; Stefanovska B; den Boestert MA; van den Borne AWM; Balcioglu HE; Trapman AM; Harris RS; Martens JWM; Span PN
Cells; 2023 Apr; 12(8):. PubMed ID: 37190094
[TBL] [Abstract][Full Text] [Related]
24. Association of high-risk human papillomavirus infection with oral epithelial dysplasia.
McCord C; Xu J; Xu W; Qiu X; McComb RJ; Perez-Ordonez B; Bradley G
Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Apr; 115(4):541-9. PubMed ID: 23522647
[TBL] [Abstract][Full Text] [Related]
25. Classical NF-κB pathway is responsible for APOBEC3B expression in cancer cells.
Maruyama W; Shirakawa K; Matsui H; Matsumoto T; Yamazaki H; Sarca AD; Kazuma Y; Kobayashi M; Shindo K; Takaori-Kondo A
Biochem Biophys Res Commun; 2016 Sep; 478(3):1466-71. PubMed ID: 27577680
[TBL] [Abstract][Full Text] [Related]
26. Downregulation of 5-hydroxymethylcytosine is associated with the progression of cervical intraepithelial neoplasia.
Kato M; Onoyama I; Kawakami M; Yoshida S; Kawamura K; Kodama K; Hori E; Cui L; Matsumura Y; Yagi H; Asanoma K; Yahata H; Itakura A; Takeda S; Kato K
PLoS One; 2020; 15(11):e0241482. PubMed ID: 33141854
[TBL] [Abstract][Full Text] [Related]
27. Upregulation of MTA1 expression by human papillomavirus infection promotes CDDP resistance in cervical cancer cells via modulation of NF-κB/APOBEC3B cascade.
Jia QP; Yan CY; Zheng XR; Pan X; Cao X; Cao L
Cancer Chemother Pharmacol; 2019 Apr; 83(4):625-637. PubMed ID: 30631898
[TBL] [Abstract][Full Text] [Related]
28. The prognostic role of sex, race, and human papillomavirus in oropharyngeal and nonoropharyngeal head and neck squamous cell cancer.
Fakhry C; Westra WH; Wang SJ; van Zante A; Zhang Y; Rettig E; Yin LX; Ryan WR; Ha PK; Wentz A; Koch W; Richmon JD; Eisele DW; D'Souza G
Cancer; 2017 May; 123(9):1566-1575. PubMed ID: 28241096
[TBL] [Abstract][Full Text] [Related]
29. m6A demethylation of cytidine deaminase APOBEC3B mRNA orchestrates arsenic-induced mutagenesis.
Gao M; Qi Z; Feng W; Huang H; Xu Z; Dong Z; Xu M; Han J; Kloeber JA; Huang J; Lou Z; Liu S
J Biol Chem; 2022 Feb; 298(2):101563. PubMed ID: 34998823
[TBL] [Abstract][Full Text] [Related]
30. Characterization of the mechanism by which the RB/E2F pathway controls expression of the cancer genomic DNA deaminase APOBEC3B.
Roelofs PA; Goh CY; Chua BH; Jarvis MC; Stewart TA; McCann JL; McDougle RM; Carpenter MA; Martens JW; Span PN; Kappei D; Harris RS
Elife; 2020 Sep; 9():. PubMed ID: 32985974
[TBL] [Abstract][Full Text] [Related]
31. APOBEC3B is preferentially expressed at the G2/M phase of cell cycle.
Hirabayashi S; Shirakawa K; Horisawa Y; Matsumoto T; Matsui H; Yamazaki H; Sarca AD; Kazuma Y; Nomura R; Konishi Y; Takeuchi S; Stanford E; Kawaji H; Murakawa Y; Takaori-Kondo A
Biochem Biophys Res Commun; 2021 Mar; 546():178-184. PubMed ID: 33592502
[TBL] [Abstract][Full Text] [Related]
32. Endogenous APOBEC3B Overexpression Constitutively Generates DNA Substitutions and Deletions in Myeloma Cells.
Yamazaki H; Shirakawa K; Matsumoto T; Hirabayashi S; Murakawa Y; Kobayashi M; Sarca AD; Kazuma Y; Matsui H; Maruyama W; Fukuda H; Shirakawa R; Shindo K; Ri M; Iida S; Takaori-Kondo A
Sci Rep; 2019 May; 9(1):7122. PubMed ID: 31073151
[TBL] [Abstract][Full Text] [Related]
33. Effect of human papillomavirus 16 oncoproteins on oncostatin M upregulation in oral squamous cell carcinoma.
Chuerduangphui J; Pientong C; Chaiyarit P; Patarapadungkit N; Chotiyano A; Kongyingyoes B; Promthet S; Swangphon P; Wongjampa W; Ekalaksananan T
Med Oncol; 2016 Aug; 33(8):83. PubMed ID: 27349249
[TBL] [Abstract][Full Text] [Related]
34. G
Yockteng-Melgar J; Shire K; Cheng AZ; Malik-Soni N; Harris RS; Frappier L
J Virol; 2022 Sep; 96(18):e0066022. PubMed ID: 36069545
[TBL] [Abstract][Full Text] [Related]
35. Activation of DNA damage repair factors in HPV positive oropharyngeal cancers.
Kono T; Hoover P; Poropatich K; Paunesku T; Mittal BB; Samant S; Laimins LA
Virology; 2020 Aug; 547():27-34. PubMed ID: 32560902
[TBL] [Abstract][Full Text] [Related]
36. Detection of human papillomavirus-16 and HPV-18 DNA in normal, dysplastic, and malignant oral epithelium.
Sugiyama M; Bhawal UK; Dohmen T; Ono S; Miyauchi M; Ishikawa T
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 May; 95(5):594-600. PubMed ID: 12738951
[TBL] [Abstract][Full Text] [Related]
37. Roles of APOBEC3A and APOBEC3B in Human Papillomavirus Infection and Disease Progression.
Warren CJ; Westrich JA; Doorslaer KV; Pyeon D
Viruses; 2017 Aug; 9(8):. PubMed ID: 28825669
[TBL] [Abstract][Full Text] [Related]
38. EGFR/PI3K/Akt/mTOR pathway in head and neck squamous cell carcinoma patients with different HPV status.
Janecka-Widła A; Majchrzyk K; Mucha-Małecka A; Biesaga B
Pol J Pathol; 2021; 72(4):296-314. PubMed ID: 35142162
[TBL] [Abstract][Full Text] [Related]
39. The prevalence and distribution of human papillomavirus genotypes in oral epithelial hyperplasia: proposal of a concept.
Varnai AD; Bollmann M; Bankfalvi A; Kovacs K; Heller H; Schmitt C; Volek J; Szendy M; Bollmann R; Hildenbrand R
J Oral Pathol Med; 2009 Feb; 38(2):181-7. PubMed ID: 19141061
[TBL] [Abstract][Full Text] [Related]
40. Ezrin-Radixin-Moesin Binding Phosphoprotein 50: A Potential Novel Biomarker in Human Papilloma Virus-Associated Head and Neck Squamous Cell Carcinomas.
Shankar A; Crouch DH; Macluskey M
Head Neck Pathol; 2019 Jun; 13(2):188-197. PubMed ID: 29846905
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
